Appointments
+(603) 5515 1966
General Line
+(603) 5515 1888
March 29, 2025
Neonatal Respiratory Distress Syndrome (RDS) is a condition that primarily affects premature newborns, leading to significant challenges for healthcare providers and families. This condition, characterised by breathing difficulties shortly after birth, is one of the leading causes of neonatal morbidity and mortality.
In this comprehensive article, we will explore everything you need to know about neonatal respiratory distress syndrome to help you be better equipped to take care of your child.
Respiratory distress syndrome (RDS) is a condition where a newborn’s lungs cannot function properly due to a lack of surfactant – a vital substance that helps keep the lungs expanded and facilitate effective gas exchange. This condition predominantly affects preterm infants born before 37 weeks of gestation.
The role of surfactant is critical; without it, the alveoli (tiny air sacs in the lungs) collapse, leading to insufficient oxygen supply and difficulty in breathing. The earlier a baby is born, the higher the likelihood of developing respiratory distress syndrome in infants due to underdeveloped lungs.
Respiratory Distress Syndrome in newborns is caused by an underdeveloped respiratory system, mainly due to insufficient production of surfactant. Surfactant coats the air sacs in the lungs, preventing them from collapsing during exhalation and allowing for efficient gas exchange.
Prematurity is the main cause of RDS in babies born before 37 weeks. Babies born extremely premature or moderately premature are at high risk due to incomplete lung development and surfactant production, leading to respiratory distress.
Maternal health issues such as diabetes, hypertension, and infections can delay foetal lung development, raising the risk of respiratory distress syndrome (RDS).
Family history and genetic mutations can increase the risk of infants developing RDS, with specific disorders affecting surfactant synthesis also contributing to the condition.
Elective caesarean deliveries before labour can increase the risk of RDS in babies, as labour helps in preparing the lungs by promoting surfactant production and clearing fluid.
Multiples such as twins or triplets are more likely to be born prematurely and at risk for respiratory distress syndrome. Uneven lung maturity can occur due to shared resources in the womb.
Certain conditions such as perinatal asphyxia and cold stress can lead to delayed production or function of surfactant in full-term babies, causing respiratory difficulties.
When preterm birth is anticipated, administering corticosteroids to the mother can significantly accelerate foetal lung maturation. Failure to receive this treatment increases the likelihood of RDS.
Male infants, particularly premature ones, are more prone to RDS than females. This disparity may be linked to slower lung development in male foetuses.
Here are the key symptoms of Respiratory Distress Syndrome in newborns:
Acute Respiratory Distress Syndrome (ARDS), is a life-threatening condition that occurs when fluid accumulates in the alveoli of the lungs, leading to severe respiratory failure. ARDS is typically triggered by underlying conditions such as severe infections (sepsis), trauma, inhalation of harmful substances, pancreatitis, or complications from surgeries. The condition impairs gas exchange, causing a significant drop in blood oxygen levels.
ARDS is a serious condition marked by symptoms such as extreme difficulty in breathing, rapid breathing, low oxygen levels, confusion, and sometimes blue discolouration of the skin due to lack of oxygen. Diagnosis involves imaging tests such as X-rays or CT scans, gas analysis, and reviewing the patient’s medical history. Treatment focuses on addressing the underlying cause, providing oxygen therapy, and in severe cases, mechanical ventilation to help with breathing. While survival rates have improved with advancements in medical care, ARDS still requires intensive care and monitoring and can have long-term effects on lung function and quality of life.
ARDS progresses through distinct stages:
In the first 24-72 hours of ARDS, there is fluid leakage leading to impaired gas exchange, inflammation, and clinical signs like rapid breathing and cyanosis.
During the proliferative stage (days 4-10), the body initiates repair of damaged alveolar walls. Inflammation persists and fluid may still be present, despite ongoing repair efforts. Oxygenation may slightly improve, but lung compliance remains poor.
ARDS can lead to lung scarring and impaired gas exchange, and if it persists for 10 days, it can progress to the fibrotic stage. This can result in stiff, non-compliant lungs and long-term complications such as chronic lung disease in babies.
Diagnosing respiratory distress syndrome (RDS) in newborns requires a systematic approach that combines clinical observation, prenatal history, and diagnostic tests. Below, we explore the key steps and tools used in diagnosing RDS in newborns.
RDS in newborns is usually detected by observing the baby’s breathing and physical signs shortly after birth. Symptoms include rapid breathing, nasal flaring, grunting sounds, chest retractions, and cyanosis (bluish skin and lips). These symptoms typically appear within the first few hours of birth and can worsen if not treated.
Gathering detailed information about the mother’s health and the baby’s gestational age provides essential clues for diagnosis. Factors that increase the risk of RDS include:
A thorough physical examination is conducted to assess the baby’s respiratory effort and overall health. This includes:
When diagnosing Respiratory Distress Syndrome, doctors can use several tests:
RDS in newborns can be confused with other conditions like Transient Tachypnoea of the Newborn (TTN), Meconium Aspiration Syndrome (MAS), Neonatal Pneumonia, and Congenital Diaphragmatic Hernia due to similar symptoms. It is important to accurately diagnose and differentiate RDS from these conditions.
Treatment for RDS focuses on improving breathing and oxygen levels, with specialised care needed for newborns.
Preventing RDS involves monitoring premature babies closely and treating lung conditions in adults.
Administering corticosteroids to pregnant women at risk of premature labour helps accelerate foetal lung development and surfactant production, reducing the likelihood and severity of RDS.
If possible, delaying preterm birth allows the foetus more time to mature and develop sufficient surfactant. Close monitoring and management of high-risk pregnancies can facilitate this.
Managing maternal health conditions (like diabetes, hypertension, or infections) to prevent early labour is crucial for reducing the incidence of RDS in newborns.
Closely monitoring multiple pregnancies (twins, triplets, etc.) and offering interventions to prevent early birth can lower RDS risk for the babies.
Elective caesarean deliveries before the onset of labour can increase the risk of RDS, as labour helps trigger the release of hormones that mature the lungs. Whenever possible, vaginal delivery should be encouraged.
Encouraging a healthy lifestyle, including proper prenatal care, avoiding smoking, and controlling pre-existing conditions, reduces the risk of complications that may lead to RDS.
Some primary complications include respiratory failure, pulmonary hypertension, and developmental issues.
Prolonged oxygen therapy and mechanical ventilation in premature infants can cause bronchopulmonary dysplasia, leading to breathing difficulties, frequent lung infections, and a lasting need for respiratory assistance.
Severe RDS can lead to high pressure in the lungs, causing pulmonary hypertension and potentially heart failure if not treated promptly.
Babies with RDS have a weakened immune system, making them more prone to infections like pneumonia and sepsis during their longer hospital stays, which can worsen lung function and recovery.
Preterm infants with RDS are more likely to experience brain bleeding, leading to potential neurological damage, developmental delays, or cerebral palsy.
Air leaks from the lungs into the chest cavity, often due to mechanical ventilation or high pressures, can cause lung collapse and may require a chest tube for treatment.
Respiratory distress syndrome in newborns remains a significant health challenge. However, advancements in medical science and early interventions have improved survival rates and outcomes. By understanding the causes, symptoms, and treatment options, parents and healthcare providers can navigate this condition with greater confidence.
If you’re caring for a newborn or an adult with respiratory distress syndrome, consulting with healthcare professionals and adhering to prescribed treatments are essential steps toward recovery.
Respiratory Distress Syndrome (RDS) is a severe condition where the lungs struggle to provide sufficient oxygen due to underdeveloped or damaged alveoli, often caused by surfactant deficiency in newborns or acute lung injury in adults.
Five signs of respiratory distress include rapid breathing, nasal flaring, chest retractions, grunting, and cyanosis (bluish skin or lips).
Three signs a baby is in respiratory distress are rapid breathing, nasal flaring, and chest retractions.
RDS is diagnosed through clinical evaluation, chest X-rays, and blood gas analysis to assess oxygen levels and lung function.
Sources:
Spread the love, follow us on our social media channels